hydroxyurea has been researched along with Dermatomyositis in 26 studies
Dermatomyositis: A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Medication-induced dermatomyositis (DM) is rare, but a recent review highlighted hydroxyurea (HU) as the most common inciting agent." | 8.88 | Hydroxyurea induced dermatomyositis-like eruption. ( Muir, J; Rodins, K; Zappala, TM, 2012) |
| "Hydroxyurea (HU) is a chemotherapeutic agent used for the treatment of myeloproliferative disorders such as chronic myeloid leukemia, polycythemia vera, and essential thrombocytosis." | 7.80 | Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema. ( Akiyama, M; Ito, E; Muro, Y; Shibata, A; Sugiura, K, 2014) |
| " Hydroxyurea-induced dermatomyositis is a rare adverse reaction of long-term hydroxyurea therapy." | 7.78 | Hydroxyurea-induced dermatomyositis: true amyopathic dermatomyositis or dermatomyositis-like eruption? ( El-Din, ES; Nofal, A, 2012) |
| "An elderly woman receiving chronic hydroxyurea therapy for myelodysplasia developed a dermatomyositis-like eruption that was misdiagnosed as true dermatomyositis, leading to continuation of hydroxyurea." | 7.76 | Hydroxyurea-associated dermatomyositis-like eruption demonstrating abnormal epidermal p53 expression: a potential premalignant manifestation of chronic hydroxyurea and UV radiation exposure. ( Burruss, JB; Callen, JP; Cely, SJ; Kalajian, AH; Malone, JC, 2010) |
| "The onset of a dermatomyositis-like rash and persistent skin ulcers during long-term treatment with hydroxyurea is a very rare event that has not been fully described in the literature." | 7.75 | [Multiple, painful, treatment-resistant leg ulcers associated with dermatomyositis-like lesions over the interphalangeal joints induced by hydroxyurea]. ( Guillén-Barona, C; Martorell-Calatayud, A; Nagore-Enguídanos, E; Requena, C, 2009) |
| "We report the case of an elderly woman who had been on hydroxyurea for long-standing widespread psoriasis." | 7.70 | Dermatomyositis-like eruption and leg ulceration caused by hydroxyurea in a patient with psoriasis. ( Lanigan, SW; Varma, S, 1999) |
| "We report on dermatomyositis-like adverse cutaneous reactions following long-term maintenance therapy with hydroxyurea in two patients suffering from chronic myelogenous leukaemia (CML)." | 7.69 | [Dermatomyositis-like skin changes with long-term hydroxyurea (Litalir) therapy]. ( Merkel, M; Pillekamp, H; Schick, E; Sterry, W; Weber, L, 1995) |
| "Medication-induced dermatomyositis (DM) is rare, but a recent review highlighted hydroxyurea (HU) as the most common inciting agent." | 4.88 | Hydroxyurea induced dermatomyositis-like eruption. ( Muir, J; Rodins, K; Zappala, TM, 2012) |
| "Hydroxyurea (HU) is a chemotherapeutic agent used for the treatment of myeloproliferative disorders such as chronic myeloid leukemia, polycythemia vera, and essential thrombocytosis." | 3.80 | Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema. ( Akiyama, M; Ito, E; Muro, Y; Shibata, A; Sugiura, K, 2014) |
| " Hydroxyurea-induced dermatomyositis is a rare adverse reaction of long-term hydroxyurea therapy." | 3.78 | Hydroxyurea-induced dermatomyositis: true amyopathic dermatomyositis or dermatomyositis-like eruption? ( El-Din, ES; Nofal, A, 2012) |
| "An elderly woman receiving chronic hydroxyurea therapy for myelodysplasia developed a dermatomyositis-like eruption that was misdiagnosed as true dermatomyositis, leading to continuation of hydroxyurea." | 3.76 | Hydroxyurea-associated dermatomyositis-like eruption demonstrating abnormal epidermal p53 expression: a potential premalignant manifestation of chronic hydroxyurea and UV radiation exposure. ( Burruss, JB; Callen, JP; Cely, SJ; Kalajian, AH; Malone, JC, 2010) |
| "The onset of a dermatomyositis-like rash and persistent skin ulcers during long-term treatment with hydroxyurea is a very rare event that has not been fully described in the literature." | 3.75 | [Multiple, painful, treatment-resistant leg ulcers associated with dermatomyositis-like lesions over the interphalangeal joints induced by hydroxyurea]. ( Guillén-Barona, C; Martorell-Calatayud, A; Nagore-Enguídanos, E; Requena, C, 2009) |
| "We report the case of an elderly woman who had been on hydroxyurea for long-standing widespread psoriasis." | 3.70 | Dermatomyositis-like eruption and leg ulceration caused by hydroxyurea in a patient with psoriasis. ( Lanigan, SW; Varma, S, 1999) |
| "We report on dermatomyositis-like adverse cutaneous reactions following long-term maintenance therapy with hydroxyurea in two patients suffering from chronic myelogenous leukaemia (CML)." | 3.69 | [Dermatomyositis-like skin changes with long-term hydroxyurea (Litalir) therapy]. ( Merkel, M; Pillekamp, H; Schick, E; Sterry, W; Weber, L, 1995) |
| "Hydroxyurea was implicated in 51% of cases." | 2.44 | Dermatomyositis induced by drug therapy: a review of case reports. ( Gottlieb, AB; Seidler, AM, 2008) |
| "Hydroxyurea is an antimetabolite primarily used to treat myeloproliferative disorders, and chronic treatment is associated with many cutaneous adverse effects ranging in severity from ichthyosis to aggressive nonmelanoma skin cancer." | 1.46 | A patient case highlighting the myriad of cutaneous adverse effects of prolonged use of hydroxyurea. ( Aires, D; Neill, B; Neill, J; Rajpara, A; Ryser, T, 2017) |
| "She was under hydroxyurea treatment for chronic myeloid leukemia at the time." | 1.33 | Gottron's papules-like eruption developing under hydroxyurea therapy. ( Kovalev, J; Lurie, M; Munichor, M; Rosner, I; Slobodin, G, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 8 (30.77) | 18.2507 |
| 2000's | 7 (26.92) | 29.6817 |
| 2010's | 9 (34.62) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Subhadarshani, S | 1 |
| Min, S | 1 |
| Holloway, K | 1 |
| Steadmon, M | 1 |
| Platto, J | 1 |
| Alexander, CE | 1 |
| Kurtzman, DJB | 1 |
| Neill, B | 1 |
| Ryser, T | 1 |
| Neill, J | 1 |
| Aires, D | 1 |
| Rajpara, A | 1 |
| Veraitch, O | 1 |
| Curto-Garcia, N | 1 |
| Harrison, C | 1 |
| Stefanato, CM | 1 |
| McGibbon, D | 1 |
| de Unamuno-Bustos, B | 1 |
| Ballester-Sánchez, R | 1 |
| Sabater Marco, V | 1 |
| Vilata-Corell, JJ | 1 |
| Ito, E | 1 |
| Muro, Y | 1 |
| Shibata, A | 1 |
| Sugiura, K | 1 |
| Akiyama, M | 1 |
| Koch, L | 1 |
| Lichem, R | 1 |
| Cerroni, L | 1 |
| Aberer, W | 1 |
| Massone, C | 1 |
| Seidler, AM | 1 |
| Gottlieb, AB | 1 |
| Janerowicz, D | 1 |
| Czarnecka-Operacz, M | 1 |
| Stawny, M | 1 |
| Silny, W | 1 |
| Martorell-Calatayud, A | 1 |
| Requena, C | 1 |
| Nagore-Enguídanos, E | 1 |
| Guillén-Barona, C | 1 |
| Kalajian, AH | 1 |
| Cely, SJ | 1 |
| Malone, JC | 1 |
| Burruss, JB | 1 |
| Callen, JP | 1 |
| Nofal, A | 1 |
| El-Din, ES | 1 |
| Zappala, TM | 1 |
| Rodins, K | 1 |
| Muir, J | 1 |
| Ruiz-Genao, DP | 1 |
| Sanz-Sánchez, T | 1 |
| Bartolomé-González, B | 1 |
| Fernández-Herrera, J | 1 |
| García-Díez, A | 1 |
| Oh, ST | 1 |
| Lee, DW | 1 |
| Lee, JY | 1 |
| Cho, BK | 1 |
| Slobodin, G | 1 |
| Lurie, M | 1 |
| Munichor, M | 1 |
| Kovalev, J | 1 |
| Rosner, I | 1 |
| Weber, L | 1 |
| Schick, E | 1 |
| Merkel, M | 1 |
| Pillekamp, H | 1 |
| Sterry, W | 1 |
| Perrot, JL | 1 |
| Cambazard, F | 1 |
| Leber, B | 1 |
| Walker, IR | 1 |
| Rodriguez, A | 1 |
| McBride, JA | 1 |
| Carter, R | 1 |
| Brain, MC | 1 |
| Senet, P | 1 |
| Aractingi, S | 1 |
| Porneuf, M | 1 |
| Perrin, P | 1 |
| Duterque, M | 1 |
| Bahadoran, P | 1 |
| Castanet, J | 1 |
| Lacour, JP | 1 |
| Perrin, C | 1 |
| Del Giudice, P | 1 |
| Mannocci, N | 1 |
| Fuzibet, JG | 1 |
| Ortonne, JP | 1 |
| Kirby, B | 1 |
| Rogers, S | 1 |
| Vélez, A | 1 |
| López-Rubio, F | 1 |
| Moreno, JC | 1 |
| Varma, S | 1 |
| Lanigan, SW | 1 |
| Rocamora, V | 1 |
| Puig, L | 1 |
| Alomar, A | 1 |
| Richard, M | 1 |
| Truchetet, F | 1 |
| Friedel, J | 1 |
| Leclech, C | 1 |
| Heid, E | 1 |
3 reviews available for hydroxyurea and Dermatomyositis
| Article | Year |
|---|---|
Dermatomyositis induced by drug therapy: a review of case reports.
Topics: Adult; Aged; Antibodies, Antinuclear; Autoimmune Diseases; Cyclophosphamide; Dermatomyositis; Etopos | 2008 |
Hydroxyurea induced dermatomyositis-like eruption.
Topics: Aged; Anemia, Megaloblastic; Antineoplastic Agents; Dermatomyositis; Drug Eruptions; Female; Humans; | 2012 |
Hydroxyurea-induced dermatomyositis-like eruption.
Topics: Aged; Antineoplastic Agents; Dermatomyositis; Drug Eruptions; Female; Humans; Hydroxyurea; Male; Mid | 1995 |
23 other studies available for hydroxyurea and Dermatomyositis
| Article | Year |
|---|---|
Clinical Images: Hydroxyurea-induced dermatomyositis-like rash.
Topics: Dermatomyositis; Drug Eruptions; Exanthema; Humans; Hydroxyurea | 2022 |
A Violaceous, Photodistributed Cutaneous Eruption and Leg Ulcer in a Woman With Essential Thrombocytosis.
Topics: Aged; Biopsy, Needle; Dermatomyositis; Exanthema; Female; Follow-Up Studies; Humans; Hydroxyurea; Im | 2018 |
A patient case highlighting the myriad of cutaneous adverse effects of prolonged use of hydroxyurea.
Topics: Aged; Biopsy; Carcinoma, Squamous Cell; Dermatomyositis; Humans; Hydroxyurea; Keratosis; Male; Polyc | 2017 |
Hydroxyurea-induced dermatomyositis koebnerizing at the site of previous shingles.
Topics: Adult; Dermatomyositis; Herpes Zoster; Humans; Hydroxyurea; Male; Polycythemia Vera; Skin | 2019 |
Dermatomyositis-like eruption associated with hydroxyurea therapy: a premalignant condition?
Topics: Aged; Dermatomyositis; Diagnosis, Differential; Drug Eruptions; Drug Substitution; Erythema; Female; | 2014 |
Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema.
Topics: Aged; Antineoplastic Agents; Dermatomyositis; Diagnosis, Differential; Erythema; Humans; Hydroxyurea | 2014 |
Dermatitis, nonmelanoma skin cancer and leg ulcers.
Topics: Aged, 80 and over; Antineoplastic Agents; Dermatomyositis; Female; Humans; Hydroxyurea; Keratosis, A | 2016 |
Dermatomyositis-like eruption induced by hydroxyurea: a case report.
Topics: Aged; Dermatomyositis; Drug Eruptions; Hand Dermatoses; Humans; Hydroxyurea; Male; Nucleic Acid Synt | 2009 |
[Multiple, painful, treatment-resistant leg ulcers associated with dermatomyositis-like lesions over the interphalangeal joints induced by hydroxyurea].
Topics: Aged; Dermatomyositis; Female; Hand Dermatoses; Humans; Hydroxyurea; Interferon alpha-2; Interferon- | 2009 |
Hydroxyurea-associated dermatomyositis-like eruption demonstrating abnormal epidermal p53 expression: a potential premalignant manifestation of chronic hydroxyurea and UV radiation exposure.
Topics: Aged, 80 and over; Dermatomyositis; Diagnosis, Differential; DNA, Neoplasm; Drug Eruptions; Epidermi | 2010 |
Hydroxyurea-induced dermatomyositis: true amyopathic dermatomyositis or dermatomyositis-like eruption?
Topics: Aged; Antineoplastic Agents; Dermatomyositis; Drug Eruptions; Female; Humans; Hydroxyurea; Leukemia, | 2012 |
Dermatomyositis-like reaction induced by chemotherapeutical agents.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; | 2002 |
Hydroxyurea-induced melanonychia concomitant with a dermatomyositis-like eruption.
Topics: Adolescent; Adult; Antineoplastic Agents; Dermatomyositis; Drug Eruptions; Humans; Hydroxyurea; Leuk | 2003 |
Gottron's papules-like eruption developing under hydroxyurea therapy.
Topics: Biopsy; Coronary Angiography; Dermatologic Surgical Procedures; Dermatomyositis; Fatal Outcome; Fema | 2006 |
[Dermatomyositis-like skin changes with long-term hydroxyurea (Litalir) therapy].
Topics: Aged; Biopsy; Dermatomyositis; Diagnosis, Differential; Dose-Response Relationship, Drug; Facial Der | 1995 |
[A case for diagnosis: Hydrea pseudo-dermatomyositis].
Topics: Dermatomyositis; Female; Humans; Hydroxyurea; Middle Aged; Polycythemia Vera | 1994 |
Reinduction of remission of chronic myeloid leukemia by donor leukocyte transfusion following relapse after bone marrow transplantation: recovery complicated by initial pancytopenia and late dermatomyositis.
Topics: Adult; Bone Marrow Transplantation; Chronic Disease; Combined Modality Therapy; Dermatomyositis; Fem | 1993 |
Pseudo-dermatomyositis induced by long-term hydroxyurea therapy: report of two cases.
Topics: Antineoplastic Agents; Dermatomyositis; Drug Eruptions; Humans; Hydroxyurea; Male; Middle Aged | 1996 |
Hydroxyurea-induced dermopathy: a unique lichenoid eruption complicating long-term therapy with hydroxyurea.
Topics: Antineoplastic Agents; Dermatologic Agents; Dermatomyositis; Hematologic Neoplasms; Humans; Hydroxyu | 1998 |
Chronic hydroxyurea-induced dermatomyositis-like eruption with severe dermal elastosis.
Topics: Antineoplastic Agents; Chronic Disease; Dermatomyositis; Drug Eruptions; Hand Dermatoses; Humans; Hy | 1998 |
Dermatomyositis-like eruption and leg ulceration caused by hydroxyurea in a patient with psoriasis.
Topics: Aged; Aged, 80 and over; Dermatologic Agents; Dermatomyositis; Drug Eruptions; Female; Humans; Hydro | 1999 |
Dermatomyositis-like eruption following hydroxyurea therapy.
Topics: Antineoplastic Agents; Dermatomyositis; Humans; Hydroxyurea; Leukemia, Myeloid; Male; Middle Aged; S | 2000 |
Skin lesions simulating chronic dermatomyositis during long-term hydroxyurea therapy.
Topics: Biopsy; Dermatomyositis; Diagnosis, Differential; Female; Humans; Hydroxyurea; Keratosis; Middle Age | 1989 |